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Abstract
Efforts to adopt public health policies that would limit the consumption of unhealthy commodities, such as
tobacco, alcohol and ultra-processed food products, are often undermined by private sector actors whose profits
depend on the sales of such products. There is ample evidence showing that these corporations not only try to
influence public health policy; they also shape research, practice and public opinion. Globalization, trade and
investment agreements, and privatization, amongst other factors, have facilitated the growing influence of private
sector actors on public health at both national and global levels. Protecting and promoting public health from the
undue influence of private sector actors is thus an urgent task. With this backdrop in mind, we launched the
“Governance, Ethics, and Conflicts of Interest in Public Health” Network (GECI-PH Network) in 2018. Our network
seeks to share, collate, promote and foster knowledge on governance, ethical, and conflicts of interest that arise in
the interactions between private sectors actors and those in public health, and within multi-stakeholder
mechanisms where dividing lines between different actors are often blurred. We call for strong guidance to address
and manage the influence of private sector actors on public health policy, research and practice, and for dialogue
on this important topic. Our network recently reached 119 members. Membership is diverse in composition and
expertise, location, and institutions. We invite colleagues with a common interest to join our network.
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Background
The consumption of unhealthy commodities, such as
cigarettes, alcohol and ultra-processed food products is
associated with ill-health [1]. Markets in high income
countries are saturated with these products, and there-
fore private sector actors are rapidly shifting to penetrate
emerging markets in low and middle income countries
[1]. Efforts to develop public policies to limit consump-
tion of these unhealthy commodities across the globe,
including from governments, have been undermined by
private sector actors [2] (or ‘industry actors’, two terms
that we used interchangeably in the present manuscript),
with the support of trade associations and front groups.
Industry actors employ a diverse range of political strat-
egies to influence public health research, policy, and
practice, to persuade governments and the public of
their potential legitimacy, and to present themselves as
responsible partners in public health (further referred to
as ‘undue influence from private sector actors’ in this
commentary) [3]. This undue influence has been ex-
posed during the current COVID-19 pandemic, with
corporations profiting from the pandemic through, for
example, their lobbying aggressively for classifying
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unhealthy commodities, such as cigarettes and alco-
hol, as essential goods, and by projecting them-
selves as responsible companies by donating
personal protective equipment and medical devices
to governments under national response to COVID-
19 [4].
Kickbusch et al. refer to a broader range of “strategies
and approaches used by the private sector to promote
products and choices that are detrimental to health”, as
the ‘commercial determinants of health’ [5]. Kickbusch
et al. explain that marketing, lobbying and other undue
influence from private sector actors are led by global
drivers of ill-health [5]. Undue influence operates at na-
tional and global levels, where globalization, trade and
investment agreements, and privatization, amongst other
neo-liberal policies, have indeed facilitated the growing
influence of private sector actors on public health. In
turn, private sector actors also shape these global drivers
of ill-health, through their participation in platforms like
the World Trade Organization and Codex Alimentarius.
The United Nations Sustainable Development Goal (UN
SDG) 17 is perhaps the best illustration of the increasing
ideological pressure to develop public private partner-
ships as a way of promoting human wellbeing. In the
wake of continuing declines in public funding for re-
search and advocacy, many individuals and institutions,
including the World Health Organization (WHO), now
engage with these private sector actors without any
substantive conditions or constraints to avoid undue
influence. Within multi-stakeholder mechanisms,
dividing lines between different actors are often
blurred.
In response, there is a growing counter-response by
public health professionals concerned about undue influ-
ence from private sector actors, particularly the impact
on governance, ethics, and conflicts of interest. These
concerns have resulted in the publication of numerous
peer-reviewed articles, casebooks, blog posts, reports,
and research meetings that have highlighted these issues,
and provided evidence of the lack of transparency and
appropriate guidance to address and manage undue in-
fluence [6]. The WHO Framework Convention on To-
bacco Control is the only international treaty that has
been successful in protecting public policies from undue
influence from private sector actors, through the imple-
mentation of its Article 5.3 on the engagement with the
tobacco industry [7]. Similar approaches have yet to be
adopted to protect public health from undue
influence from private sector actors in the alcohol,
gambling, and ultra-processed food industries,
amongst others. Policies to address any undue in-
fluence are not only needed at the UN and govern-
ment levels, but also for academia and civil society
organizations.
Main text
With this global backdrop in mind, a group of public
health professionals from around the globe, concerned
about the undue influence of private sector actors on
public health were invited to a meeting in February 2018
at the Faculty of Health Sciences at the American Uni-
versity of Beirut, Lebanon, funded by the International
Development Research Center (IDRC), Canada. There,
we discussed our research experiences and knowledge;
and we set a research agenda for the protection and pro-
motion of public health policies and practices. The
meeting started with the recognition that accepting
funds from and engaging with certain private sector ac-
tors, such as those that produce and sell unhealthy com-
modities and their front offices, result in ethical and
practical challenges. Towards the end of the meeting, we
decided to launch the “Governance, Ethics, and Conflicts
of Interest in Public Health” Network (GECI-PH Net-
work). In doing so, we used the medical definition of
conflict of interest (COI), also used by the WHO, where
a set of conditions in which professional judgment con-
cerning one interest may be unduly influenced by an-
other interest, such as financial benefit [8]. We defined
ethics in this context as value-based justification of pol-
icies and programs to advance population health, while
governance for public health refers to the interactions of
state institutions and non-state actors in collectively
creating conditions for optimizing population health [9].
We chose a network as a working mechanism since
networks connect researchers that are working in differ-
ent global regions around a common research agenda,
and allows the creation of joint projects while simultan-
eously allowing for support, mentorship and guidance
on individual projects; and sharing of lessons learned in
one context to inform another. Networks thus are spider
webs of connections for maximum co-learning and co
creation opportunities. They can be loose and strong
simultaneously, building on assets, expertise, and rela-
tionships of each member.
The network has seven objectives: i) sharing know-
ledge of undue influence from private sector actors in
public health research, practice, and policy; ii) docu-
menting the governance, ethical, and COI issues that
arise in the interactions between individuals and institu-
tions in public health and those from the private sector;
iii) encouraging research into and providing recommen-
dations about best practices in governance and man-
aging of ethical and COI concerns in these interactions;
iv) sharing lessons learned and responses related to un-
due influence from private sector actors on public health
at a local, national, regional and global level; v) actively
demanding limits on the engagement with industry ac-
tors in public health; vi) fostering policy dialogue around
this topic; and vii) conducting research that helps set
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priorities on governance, ethics, and conflicts of interest
(COI) in public health.
After our first meeting, we undertook a Delphi process
amongst our members and their extended network (only
including those individuals who had no COI) to identify
relevant research gaps and priorities. The Delphi ques-
tionnaire included research topics that were identified
by participants of the 2018 GECI-PH meeting and from
a recent research agenda on transnational corporations
and health developed by Baum and Anaf [10]. Baum and
Anaf’s research agenda focuses on the impact of private
sector actors on health and equity; effectiveness of gov-
ernment efforts to address these negative impacts; the
role and work of advocates; and regulation of capitalism
for a healthier and more equitable private sector [10].
Principal research gaps identified through our Delphi
process related to: i) identifying tactics used by corpora-
tions to unduly influence public health policy, research
and practice; ii) identifying frameworks, policies, and
tools that can be used to support public health to govern
effectively and control COI and undue influence from
private sector actors; iii) developing communication
messages to increase awareness of the ethical and prac-
tical challenges associated with COI and undue influence
from private sector actors; iv) exploring global trade bar-
riers that impede an agenda of COI management for
governments; v) identifying policies to govern and limit
conflicts of interest in relation to universities and
engagement with corporate actors.
We had a second annual meeting in Beirut in March
2019, attended by 25 members. During that meeting, we
discussed the results of the Delphi process and collect-
ively decided to focus on four research gaps, as a net-
work: i) mapping tactics of health-harming industries to
unduly influence public health policy, practice and re-
search; ii) policies to limit and manage COI and undue
influence from private sector actors in public health; iii)
best strategies for strengthening understanding of and
capacity to manage COI amongst public health actors;
and iv) global trade policies that have enabled undue in-
fluence from private sector actors on public health. Fur-
ther work funded through a Wellcome Trust grant will
explore new methodologies for researching the relation-
ship between corporations and public health.
The GECI-PH Network provides a platform for its
members to interact, share relevant resources and co-
ordinate research and advocacy efforts. The Network
had expanded since its inception and recently reached
119 members. Membership is diverse in composition
and expertise (experts on the alcohol, tobacco, food and
other industries), location (all continents), and institu-
tions (academia, practitioner, civil society). Our network
is accessible through its website (https://aub.edu.lb/fhs/
Pages/GECI.aspx) and Twitter handle (@GECI_ph),
sends regular updates to its members by email and pub-
lishes a newsletter twice a year. We organized two panel
discussions at the 2018 American Public Health Associ-
ation and European Public Health Association annual
conferences. We organized a World Leadership Dialogue
at the 2020 World Congress on Public Health. With
support from IDRC, we have funded three research pro-
jects led by early career researchers and/or researchers
from low and middle income countries, on topics
aligned with the objectives of our Network. We have
supported members facing undue influence from private
sector actors on their institutions by providing support
for lobbying and advocacy to prevent such co-option.
The Network has also organized a series of webinars on
the commercial determinants of health and solutions to
address harmful corporate practices, with recordings
available on our website.
Conclusions
The GECI-PH network calls for appropriate guidance to
address and manage undue influence from private sector
actors on public health policy, research and practice, and
aims to foster dialogue on this important topic. We ac-
knowledge the increased research and advocacy actions
around these issues by various institutions and individ-
uals. We understand that each may come from slightly
different backgrounds or starting points. We are eager
to partner with other entities as our success is only in
working together. We need to also expand our network
beyond health, as private sector actors also influence
public policy in other fields covered by the UN SDGs,
including education (SDG4), water and sanitation
(SDG6), climate (SDG13), peace and justice (SDG16).
We strongly believe that our strength will be in our
numbers, in our combined expertise and commitments,
and in producing and disseminating evidence for
decision making.
You could join the GECI-PH Network by sending an
email to: gecoi.ph@gmail.com
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